Growth Metrics

Neurocrine Biosciences (NBIX) Interest Expenses: 2017-2021

Historic Interest Expenses for Neurocrine Biosciences (NBIX) over the last 5 years, with Sep 2021 value amounting to $6.6 million.

  • Neurocrine Biosciences' Interest Expenses fell 22.35% to $6.6 million in Q3 2021 from the same period last year, while for Sep 2021 it was $27.7 million, marking a year-over-year decrease of 16.47%. This contributed to the annual value of $32.0 million for FY2019, which is 4.69% up from last year.
  • According to the latest figures from Q3 2021, Neurocrine Biosciences' Interest Expenses is $6.6 million, which was up 6.45% from $6.2 million recorded in Q2 2021.
  • In the past 5 years, Neurocrine Biosciences' Interest Expenses registered a high of $8.5 million during Q3 2020, and its lowest value of $4.8 million during Q2 2017.
  • In the last 3 years, Neurocrine Biosciences' Interest Expenses had a median value of $8.0 million in 2019 and averaged $7.6 million.
  • As far as peak fluctuations go, Neurocrine Biosciences' Interest Expenses surged by 59.24% in 2018, and later dropped by 25.30% in 2021.
  • Quarterly analysis of 5 years shows Neurocrine Biosciences' Interest Expenses stood at $7.4 million in 2017, then increased by 4.64% to $7.8 million in 2018, then grew by 5.15% to $8.2 million in 2019, then climbed by 6.25% to $8.5 million in 2020, then dropped by 22.35% to $6.6 million in 2021.
  • Its Interest Expenses stands at $6.6 million for Q3 2021, versus $6.2 million for Q2 2021 and $6.4 million for Q1 2021.